These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 15711722

  • 41. The impact of FDG positron emission tomography imaging on the management of lymphomas.
    Shah N, Hoskin P, McMillan A, Gibson P, Lowe J, wong WL.
    Br J Radiol; 2000 May; 73(869):482-7. PubMed ID: 10884743
    [Abstract] [Full Text] [Related]

  • 42. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
    Shen YY, Kao A, Yen RF.
    Oncol Rep; 2002 May; 9(2):321-5. PubMed ID: 11836600
    [Abstract] [Full Text] [Related]

  • 43. Whole-body hybrid PET with 18F-FDG in the staging of non-Hodgkin's lymphoma.
    Tatsumi M, Kitayama H, Sugahara H, Tokita N, Nakamura H, Kanakura Y, Nishimura T.
    J Nucl Med; 2001 Apr; 42(4):601-8. PubMed ID: 11337549
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. 18F-FDG PET in malignant lymphoma: significance of positive findings.
    Castellucci P, Zinzani P, Pourdehnad M, Alinari L, Nanni C, Farsad M, Battista G, Tani M, Stefoni V, Canini R, Monetti N, Rubello D, Alavi A, Franchi R, Fanti S.
    Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):749-56. PubMed ID: 15785956
    [Abstract] [Full Text] [Related]

  • 46. Positron emission tomography (PET) for staging and evaluation of response to treatment in patients with Hodgkin's disease.
    Wiedmann E, Baican B, Hertel A, Baum RP, Chow KU, Knupp B, Adams S, Hör G, Hoelzer D, Mitrou PS.
    Leuk Lymphoma; 1999 Aug; 34(5-6):545-51. PubMed ID: 10492078
    [Abstract] [Full Text] [Related]

  • 47. The role of 18F-FDG PET/CT for initial staging of nasal type natural killer/T-cell lymphoma: a comparison with conventional staging methods.
    Moon SH, Cho SK, Kim WS, Kim SJ, Chan Ahn Y, Choe YS, Lee KH, Kim BT, Choi JY.
    J Nucl Med; 2013 Jul; 54(7):1039-44. PubMed ID: 23658217
    [Abstract] [Full Text] [Related]

  • 48. Correlation between glycolytic activity on [18F]-FDG-PET and cell density on diffusion-weighted MRI in lymphoma at staging.
    Giraudo C, Karanikas G, Weber M, Raderer M, Jaeger U, Simonitsch-Klupp I, Mayerhoefer ME.
    J Magn Reson Imaging; 2018 May; 47(5):1217-1226. PubMed ID: 29086453
    [Abstract] [Full Text] [Related]

  • 49. Consistency of FDG-PET accuracy and cost-effectiveness in initial staging of patients with Hodgkin lymphoma across jurisdictions.
    Cerci JJ, Trindade E, Buccheri V, Fanti S, Coutinho AM, Zanoni L, Linardi CC, Celli M, Delbeke D, Pracchia LF, Pitela FA, Soares J, Zinzani PL, Meneghetti JC.
    Clin Lymphoma Myeloma Leuk; 2011 Aug; 11(4):314-20. PubMed ID: 21816369
    [Abstract] [Full Text] [Related]

  • 50. Can diffusion-weighted whole-body MRI replace contrast-enhanced CT for initial staging of Hodgkin lymphoma in children and adolescents?
    Regacini R, Puchnick A, Luisi FAV, Lederman HM.
    Pediatr Radiol; 2018 May; 48(5):638-647. PubMed ID: 29362839
    [Abstract] [Full Text] [Related]

  • 51. Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography.
    Stumpe KD, Urbinelli M, Steinert HC, Glanzmann C, Buck A, von Schulthess GK.
    Eur J Nucl Med; 1998 Jul; 25(7):721-8. PubMed ID: 9662594
    [Abstract] [Full Text] [Related]

  • 52. Whole-body MRI versus an [18F]FDG-PET/CT-based reference standard for early response assessment and restaging of paediatric Hodgkin's lymphoma: a prospective multicentre study.
    Spijkers S, Littooij AS, Kwee TC, Tolboom N, Beishuizen A, Bruin MCA, Enríquez G, Sábado C, Miller E, Granata C, de Lange C, Verzegnassi F, de Keizer B, Nievelstein RAJ.
    Eur Radiol; 2021 Dec; 31(12):8925-8936. PubMed ID: 34021390
    [Abstract] [Full Text] [Related]

  • 53. Comparison of 18F FDG PET-CT AND CECT in pretreatment staging of adults with Hodgkin's lymphoma.
    Panebianco M, Bagni O, Cenfra N, Mecarocci S, Ortu La Barbera E, Filippi L, Codacci-Pisanelli G, Biondi T, Laghi A, Cimino G.
    Leuk Res; 2019 Jan; 76():48-52. PubMed ID: 30553980
    [Abstract] [Full Text] [Related]

  • 54. (18)F-FDG PET and conventional imaging for assessment of Hodgkin's disease and non Hodgkin's lymphoma. An analysis of 193 patient studies.
    Bucerius J, Herkel C, Joe AY, Altehoefer C, Finke J, Moser E, Reinhardt MJ.
    Nuklearmedizin; 2006 Jan; 45(3):105-10; quiz N25-6. PubMed ID: 16710505
    [Abstract] [Full Text] [Related]

  • 55. Characterizing bone marrow involvement in Hodgkin's lymphoma by FDG-PET/CT.
    Weiler-Sagie M, Kagna O, Dann EJ, Ben-Barak A, Israel O.
    Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1133-40. PubMed ID: 24570095
    [Abstract] [Full Text] [Related]

  • 56. 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial.
    Buchmann I, Reinhardt M, Elsner K, Bunjes D, Altehoefer C, Finke J, Moser E, Glatting G, Kotzerke J, Guhlmann CA, Schirrmeister H, Reske SN.
    Cancer; 2001 Mar 01; 91(5):889-99. PubMed ID: 11251940
    [Abstract] [Full Text] [Related]

  • 57. High SUV uptake on FDG-PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma.
    Ngeow JYY, Quek RHH, Ng DCE, Hee SW, Tao M, Lim LC, Tan YH, Lim ST.
    Ann Oncol; 2009 Sep 01; 20(9):1543-1547. PubMed ID: 19474116
    [Abstract] [Full Text] [Related]

  • 58. Computed tomography and 18F-FDG positron emission tomography for therapy control of Hodgkin's and non-Hodgkin's lymphoma patients: when do we really need FDG-PET?
    Reinhardt MJ, Herkel C, Altehoefer C, Finke J, Moser E.
    Ann Oncol; 2005 Sep 01; 16(9):1524-9. PubMed ID: 15946979
    [Abstract] [Full Text] [Related]

  • 59. Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma.
    Afaq A, Fraioli F, Sidhu H, Wan S, Punwani S, Chen SH, Akin O, Linch D, Ardeshna K, Lambert J, Miles K, Groves A, Kayani I.
    Clin Nucl Med; 2017 Jan 01; 42(1):e1-e7. PubMed ID: 27607161
    [Abstract] [Full Text] [Related]

  • 60. Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma.
    Hoh CK, Glaspy J, Rosen P, Dahlbom M, Lee SJ, Kunkel L, Hawkin RA, Maddahi J, Phelps ME.
    J Nucl Med; 1997 Mar 01; 38(3):343-8. PubMed ID: 9074514
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.